Видео с ютуба Julie Brahmer

Dr. Julie Brahmer Invites you to the 18th Annual Winter Lung Cancer Conference®

Immunotherapy for Lung Cancer: What Patients Need to Know, with Julie Brahmer

Dr. Julie R. Brahmer on Immunotherapy Development in Lung Cancer

KMTV Omaha - Interview with Omaha native, Dr. Julie Brahmer

Dr. Julie R. Brahmer Invites You to The 19th Annual Winter Lung Cancer Conference®

Interview with (Dr. Julie R. Brahmer) - The highlights of IASLC 2020 NACLC

Dr. Julie Brahmer on the PD-1 Targeted Immunotherapy BMS-93655 Clinical Trial

Julie Brahmer, MD - Pleural Mesothelioma - 2009 Mesothelioma Foundation Symposium

Julie Brahmer, MD, on the importance of overall cost of therapy

Julie Brahmer, MD, discusses considerations when choosing between immunotherapy and chemotherapy

What is Dr. Julie R. Brahmer looking forward to at the 18th Annual Winter Lung Cancer Conference®?

Dr Julie Brahmer : Lung Cancer Immunotherapy

Dr. Julie R. Brahmer on the "can't miss" lectures at the 18th Annual Winter Lung Cancer Conference®

Julie Brahmer, MD, on the level of PD-L1 expression in selecting the appropriate agent in NSCLC

Julie Brahmer, MD, talks about the potential impact of immunotherapy in 1st line NSCLC

Julie Brahmer, MD, on positioning of ramucirumab (Cyramza) post-platinum therapy in NSCLC patients

Cancer Immunotherapy in Lung Cancer Discussed by Dr. Julie Brahmer

Julie Brahmer, MD, provides practical advice related to PD-L1 testing in NSCLC patients

Dr. Brahmer Discusses the Outlook for Immunotherapies

Dr. Julie Brahmer named Meyerhoff Professor in Thoracic Oncology